Rationale for dopa-responsive CTNNB1/ß-catenin deficient dystonia

Mov Disord. 2018 Apr;33(4):656-657. doi: 10.1002/mds.27320. Epub 2018 Feb 13.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Child, Preschool
  • Dopamine Agents / therapeutic use*
  • Dystonic Disorders / drug therapy*
  • Dystonic Disorders / genetics*
  • Female
  • Humans
  • Levodopa / therapeutic use*
  • Longitudinal Studies
  • beta Catenin / deficiency*
  • beta Catenin / genetics*

Substances

  • CTNNB1 protein, human
  • Dopamine Agents
  • beta Catenin
  • Levodopa

Supplementary concepts

  • Dystonia, Dopa-responsive